Ovaprene phase 1: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the ovaprene vaginal device clinical trial
Ended Awarded Last action
- Contract number
- 75N94023F00001
- Awardee
-
The Trustees Of The University Of Pennsylvania UEI GM1XX56LEP58
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $316,281
Award facts
- Contract value 100% obligated
- $316,280.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 15 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Philadelphia, PA 19104, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $149,066 | |
| Additional Work (new agreement, FAR part 6 applies) | $75,181 | |
| Original award | $92,034 |
About this award
This federal contract award was issued by the National Institute of Child Health and Human Development, a civilian agency, to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The $316,280.79 cost-no-fee contract supports the OVAPRENE PHASE 1 effort, including protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the OVAPRENE vaginal device clinical trial. The contract does not have a set-aside designation. As a renowned private research university and academic medical center, the University of Pennsylvania has an extensive history of conducting cutting-edge biomedical research and providing a variety of healthcare services to federal agencies through contracts and grants. This contract award is part of the university's larger portfolio of federal contract vehicles and grant awards, which have supported research, development, and healthcare delivery initiatives across numerous fields, often in collaboration with other institutions.
Quick answers
Who was awarded contract 75N94023F00001?
75N94023F00001 was awarded to The Trustees Of The University Of Pennsylvania by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00001 worth?
The government has obligated $316,281 on 75N94023F00001.
Is contract 75N94023F00001 an order under another contract?
Yes. 75N94023F00001 is a delivery order under 75N94020D00005, an indefinite delivery contract.
Was contract 75N94023F00001 competed?
The extent of competition for 75N94023F00001 was full and open competition. The government received 15 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award